Corina

Local-released of 17-β Estradiol (over 60 days)

1. Avoids “first-pass effects”
2. Minimizes systemic exposure vs. oral estrogen therapy
3. Provides continuous low-dose hormone release at the site of action

Physical Barrier to Prevent Adhesion Formation

1. Supports structural integrity while the endometrium regenerates
2. Particularly beneficial for patients at high risk of re-adhesion after TCRA or intrauterine trauma.